icgebcontao.icgeb.org/tl_files/meetings/2018/serbia2018/srb1802_flyer.pdf · meetings and courses...
TRANSCRIPT
Meetings and Courses 2018ICGEB
ICGEB Meetings and Courses UnitPadriciano, 99I-34149 Trieste, ItalyTel: +39-040-3757332/7333Fax: +39-040-226555E-mail: [email protected]
http://www.icgeb.org/meetings-2018.html
17-18May
Workshop “New biotechnological drugs and biosimilars with focus on Danube and Adriatic-Ionian macroregion: a case for smart specialization in research and innovation”Belgrade, SERBIA
Organiser:Jelena Begovic (IMGGE, University of Belgrade, Serbia)Co-organisers:Marco Baralle and Natasa Skoko (ICGEB Trieste, Italy)
Contact [email protected], [email protected], [email protected] Web http://www.icgeb.org/serbia-smart-specialisation-2018.html
The workshop aims at providing a forum for discussion between stakeholders, experts from the private sector, as well as from the public domain, to share knowledge and experience from the field of biosimilars and to formulate recommendations on national and regional level towards increasing smart specialization, competitiveness and strengthening the regional integration into European research and innovation programs. Topics will include:
• Biosimilar and generic pharmaceutical development• Local manufacturing• Smart specialization• Technology transfer
Participants
• Attendance is by invitation. A limited number of seats will be available for scientists and policy makers involved inbiopharmaceutical R&D and willing to present their current research/work
• Interested participants must apply online including their CV and motivation letter
Funding
• A limited number of grants to cover accommodation and meals will be available for selected participants holdingstrategic positions in government, educational and industry institutions who are nationals of an ICGEB Member State
• The grant will cover transport costs and hotel accommodation
Online application http://www.icgeb.org/course-application-serbia-2018.htmlDeadline 4 May 2018
Follow the event #ICGEBmeeting #PharmaceuticalDevelopment #Biosimilars